Complete Your Health Assessment
Provide information about your health history, medications and weight-management goals.
Personalized compounded semaglutide has become one of the most widely discussed medications in medical weight management.
Understanding personalized compounded semaglutide means looking beyond the headlines.
Personalized compounded semaglutide is a glucagon-like peptide-1, or GLP-1, receptor agonist.
Bodi Envi connects eligible patients with licensed healthcare providers who can evaluate whether an available treatment option is medically appropriate based on the patient's individual health information.
Some Bodi Envi programs may involve personalized compounded semaglutide when prescribed by a licensed healthcare provider and permitted under applicable law.
Personalized compounded semaglutide is not FDA-approved and is not equivalent to an FDA-approved semaglutide product. Personalized compounded semaglutide is not regulated by the FDA, but it is regulated by the board of pharmacy for sterile compounding and required to follow US pharmacopeia standards.
Bodi Envi does not manufacture or compound medication.
Personalized compounded semaglutide belongs to a class of medications that act at GLP-1 receptors.
GLP-1 is a naturally occurring hormone involved in several processes related to appetite, digestion and glucose regulation.
Medications that activate GLP-1 receptors can influence these pathways.
Personalized compounded semaglutide has been studied extensively in FDA-approved formulations for specific medical indications. Personalized compounded semaglutide cannot be compared to brand product studies.
Personalized compounded semaglutide activates GLP-1 receptors.
GLP-1 signaling is involved in communication between the digestive system, pancreas and brain.
Among its effects, GLP-1 receptor activation can influence:
Appetite
Satiety
Food intake
Gastric emptying
Insulin secretion
Glucagon regulation
For some patients, these effects may make it easier to feel satisfied with smaller amounts of food.
Individual responses vary.
One of the reasons personalized compounded semaglutide is used in medical weight management is its effect on appetite and satiety.
Some patients may notice:
Less hunger
Feeling full sooner during meals
Staying satisfied longer
Reduced interest in food
Easier portion control
These experiences vary considerably between individuals.
The goal of treatment is not to eliminate eating.
Maintaining adequate nutrition remains important during weight loss.
Semaglutide is the active ingredient in FDA-approved prescription medications for specific indications.
Different personalized compounded semaglutide products may have different:
Approved indications
Dosing schedules
Formulations
Instructions
Warnings
Patients should not assume that every product containing semaglutide is interchangeable.
Understanding FDA-Approved vs Personalized Compounded Medications
Personalized compounded medications are prepared by compounding pharmacies for individual patients when prescribed under applicable circumstances.
Personalized compounded semaglutide is not FDA-approved.
That means personalized compounded semaglutide has not undergone FDA premarket review for safety, effectiveness or quality in the way an FDA-approved medication has.
Personalized compounded semaglutide should not be described as a generic version of an FDA-approved semaglutide medication.
It is also not equivalent to an FDA-approved semaglutide product.
Bodi Envi does not manufacture or compound semaglutide.
When prescribed, medication is dispensed by VialsRx, a 503A licensed pharmacy.
There is no single treatment that is appropriate for everyone.
A licensed healthcare provider may consider factors including:
Age
Weight and weight history
Body mass index
Weight-related medical conditions
Current medications
Previous treatments
Medical history
Pregnancy status
Potential contraindications
Treatment goals
Completing a Bodi Envi assessment does not guarantee treatment or a prescription. If a patient is not eligible for treatment, a full refund is issued.
Personalized compounded semaglutide can cause side effects.
Commonly reported gastrointestinal effects with personalized compounded semaglutide products include:
Nausea
Vomiting
Diarrhea
Constipation
Abdominal discomfort
Other side effects may occur.
Patients should discuss potential risks, warnings and side effects with their healthcare provider and review the applicable prescribing information for an FDA-approved product when relevant.
Personalized compounded semaglutide is not appropriate for everyone.
Certain medical conditions, medications, pregnancy status and other health factors may affect whether treatment is appropriate.
Patients should provide their healthcare provider with complete and accurate information about:
Medical history
Current medications
Allergies
Previous reactions to medications
Pregnancy or plans for pregnancy
Relevant personal and family medical history
Patients should not begin, stop or change treatment without appropriate medical guidance.
Personalized compounded semaglutide treatment is generally introduced according to an appropriate dosing plan determined by the prescribing healthcare professional.
Dose changes should be based on the prescribed treatment plan, clinical response and tolerability.
Patients should not independently increase their dose in an attempt to accelerate weight loss.
Reduced appetite can make eating less feel easier.
But eating less does not automatically mean eating well.
Patients should continue paying attention to:
Protein
Hydration
Fiber
Fruits and vegetables
Adequate vitamins and minerals
Overall nutritional intake
Weight loss can include loss of both fat and lean tissue.
Appropriate resistance training, physical activity and adequate nutrition may help support muscle and physical function during weight loss.
Exercise recommendations should reflect the individual's health, ability and medical circumstances.
Personalized Compounded Semaglutide programs through Bodi Envi are $125 to $155 per month based on plan. The price is the same at every dose.
Pricing includes:
Provider evaluation
Medication
Supplies
Shipping
Ongoing provider access
Patient support
Dose changes
GLP-1 ebook and diet plan
Provide information about your health history, medications and weight-management goals.
A licensed healthcare provider reviews your information.
The healthcare provider determines whether treatment is medically appropriate.
If medication is prescribed, the prescription is transmitted to VialsRx, a 503A licensed compounding pharmacy, for dispensing. Bodi Envi does not manufacture or compound medication.
Patients can communicate with their care team for appropriate follow-up and treatment monitoring.
Yes. Personalized compounded semaglutide is a GLP-1 receptor agonist.
No. Personalized compounded semaglutide is not FDA-approved.
No. Personalized compounded semaglutide is not equivalent to an FDA-approved semaglutide product.
No. Individual responses vary.
No. Bodi Envi does not manufacture or compound medication.
Explore more about medical weight management and how treatment works:
Medical weight management should begin with an individual evaluation.
A licensed healthcare provider can review your medical history, medications, goals and other relevant information to determine which options, if any, may be appropriate.
Complete a secure online health assessment for review by a licensed healthcare provider.